New Delhi, July 27 -- Basel, Switzerland - Swiss pharmaceutical giant Roche is preparing to launch a pivotal late-stage clinical trial to test whether its experimental drug, trontinemab, can prevent the onset of Alzheimer's disease symptoms in individuals at high risk of cognitive decline. This marks a significant development in the race to halt the relentless progression of Alzheimer's, a [.]

Published by HT Digital Content Services with permission from The Eastern Herald....